CD200 expression in flow cytometry helps to distinguish mantle cell lymphoma from other CD5-positive B-cell neoplasms

被引:5
|
作者
Debord, Camille [1 ]
Robillard, Nelly [1 ]
Theisen, Olivier [1 ]
Gastinne, Thomas [2 ]
Godmer, Pascal [3 ]
Graveleau, Julie [4 ]
Le Gouill, Steven [2 ]
Luycx, Odile [5 ]
Tiab, Mourad [6 ]
Loirat, Marion [4 ]
Lestang, Elsa [4 ]
Wuilleme, Soraya [1 ]
Godon, Catherine [1 ]
Eveillard, Marion [1 ]
Bene, Marie Christine [1 ]
机构
[1] Nantes Univ Hosp, Hematol Biol, Nantes, France
[2] Nantes Univ Hosp, Dept Hematol, Nantes, France
[3] Bretagne Atlantique Hosp, Dept Hematol, Vannes, France
[4] St Nazaire Hosp, Dept Internal Med, St Nazaire, France
[5] Bretagne Sud Hosp, Dept Hematol, Lorient, France
[6] Vendee Hosp, Dept Hematol, La Roche Sur Yon, France
关键词
DIFFERENTIAL-DIAGNOSIS;
D O I
10.1002/hon.2511
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:607 / 609
页数:3
相关论文
共 50 条
  • [21] CD200 Expression in B-Cell Chronic Lymphoproliferative Disorders
    El Desoukey, Nermeen Ahmed
    Afify, Reham Abd Aleem
    Amin, Dalia Gamil
    Mohammed, Rasha Faragaly
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (01) : 56 - 61
  • [22] Patterns of CD24 and CD180 expression by flow cytometry can distinguish Mantle Cell Lymphoma (MCL) from other non-Hodgkin B-cell lymphoproliferative disorders (B-LPD)
    Bowers, Kelly A.
    Johnson, Cory
    Murthy, Kruthi
    Laziuk, Katsiaryna
    Hammer, Richard
    MODERN PATHOLOGY, 2018, 31 : 501 - 501
  • [23] Patterns of CD24 and CD180 expression by flow cytometry can distinguish Mantle Cell Lymphoma (MCL) from other non-Hodgkin B-cell lymphoproliferative disorders (B-LPD)
    Bowers, Kelly A.
    Johnson, Cory
    Murthy, Kruthi
    Laziuk, Katsiaryna
    Hammer, Richard
    LABORATORY INVESTIGATION, 2018, 98 : 501 - 501
  • [24] CD5-positive B-cell acute lymphoblastic leukemia
    Peterson, Michael R.
    Noskoviak, Kyle J.
    Newbury, Robert
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2007, 10 (01) : 41 - 45
  • [25] the Utility of CD200 Expression In the Differentiation of Mantle Cell Lymphoma and B-Cell Chronic Lymphocytic Leukaemia: A Single Centre Experience.
    Bhatnagar, Neha
    Wright, Faith
    McAleese, Dimpna
    McNamara, Christopher J.
    BLOOD, 2010, 116 (21) : 702 - 702
  • [26] CD5-positive B-cell neoplasms of indeterminate immunophenotype - A clinicopothologic analysis of 26 cases
    Asplund, SL
    McKenna, RW
    Doolittle, JE
    Kroft, SH
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2005, 13 (04) : 311 - 317
  • [27] The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma
    Hyo, Rie
    Tomita, Naoto
    Takeuchi, Kengo
    Aoshima, Tomohiro
    Fujita, Atsuko
    Kuwabara, Hideyuki
    Hashimoto, Chizuko
    Takemura, Sachiya
    Taguchi, Jun
    Sakai, Rika
    Fujita, Hiroyuki
    Fujisawa, Shin
    Ogawa, Koji
    Motomura, Shigeki
    Suzuki, Ritsuro
    Ishigatsubo, Yoshiaki
    HEMATOLOGICAL ONCOLOGY, 2010, 28 (01) : 27 - 32
  • [28] Flow Cytometric Expression of CD200 and CD1d in the Diagnostic Evaluation of CD5-Negative, CD10-Negative Mature B-Cell Neoplasms
    Mason, Emily
    Pozdnyakova, Olga
    Li, Betty
    Dorfman, David
    MODERN PATHOLOGY, 2015, 28 : 363A - 363A
  • [29] Flow Cytometric Expression of CD200 and CD1d in the Diagnostic Evaluation of CD5-Negative, CD10-Negative Mature B-Cell Neoplasms
    Mason, Emily
    Pozdnyakova, Olga
    Li, Betty
    Dorfman, David
    LABORATORY INVESTIGATION, 2015, 95 : 363A - 363A
  • [30] THE UTILITY OF CD200 AND CD23 EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA
    Wong, Sue
    Sartor, Mary
    Timbol, Zarah
    Bradstock, Ken
    Fulcher, David
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2011, 80B (06) : 388 - 388